MCL1 and thyroid gland carcinoma: However, two relatively sensitive cell lines (WRO82-1 and 8505C) had high basal levels of Mcl-1, raising the hypothesis that thyroid cancer cells that depend on Mcl-1 for survival may be susceptible to dinaciclib treatment.